Maldives and Sri Lanka have achieved the WHO hepatitis B control goal, with national surveys confirming zero prevalence among children due to decades of high immunization coverage. This milestone ...

Arbutus Biopharma Corporation (Nasdaq: ABUS) recently presented compelling data on its investigational hepatitis B therapies, ...

Vir Bio (VIR) reveals 24-week post-end-of-treatment data from a mid-stage trial for its Hep B therapy developed with Xencor ...